Modeling Pathogenesis of Huntington’s Disease with Inducible Neuroprogenitor Cells

被引:0
|
作者
G. Dong
J. M. Ferguson
A. J. Duling
R. G. Nicholas
D. Zhang
K. Rezvani
S. Fang
M. J. Monteiro
S. Li
X-J. Li
H. Wang
机构
[1] University of South Dakota,Division of Basic Biomedical Sciences, Sanford School of Medicine
[2] University of South Dakota,Department of Biology
[3] University of Maryland,Center for Biomedical Engineering and Technology
[4] Emory University School of Medicine,Department of Human Genetics
来源
Cellular and Molecular Neurobiology | 2011年 / 31卷
关键词
Huntington’s disease; Pathogenesis; Huntingtin; Polyglutamine; Neuron; Neuroprogenitor;
D O I
暂无
中图分类号
学科分类号
摘要
Huntington’s disease (HD) is caused by an abnormal expansion of CAG trinucleotide repeats encoding polyglutamine (polyQ) in the first exon of the huntingtin (htt) gene. Despite considerable efforts, the pathogenesis of HD remains largely unclear due to a paucity of models that can reliably reproduce the pathological characteristics of HD. Here, we report a neuronal cell model of HD using the previously established tetracycline regulated rat neuroprogenitor cell line, HC2S2. Stable expression of enhanced green fluorescence protein tagged htt exon 1 (referred to as 28Q and 74Q, respectively) in the HC2S2 cells did not affect rapid neuronal differentiation. However, compared to the cells expressing wild type htt, the cell line expressing mutant htt showed an increase in time-dependent cell death and neuritic degeneration, and displayed increased vulnerability to oxidative stress. Increased protein aggregation during the process of neuronal aging or when the cells were exposed to oxidative stress reagents was detected in the cell line expressing 74Q but not in its counterpart. These results suggest that the neuroprogenitor cell lines mimic the major neuropathological characteristics of HD and may provide a useful tool for studying the neuropathogenesis of HD and for high throughput screening of therapeutic compounds.
引用
收藏
页码:737 / 747
页数:10
相关论文
共 50 条
  • [1] Modeling Pathogenesis of Huntington's Disease with Inducible Neuroprogenitor Cells
    Dong, G.
    Ferguson, J. M.
    Duling, A. J.
    Nicholas, R. G.
    Zhang, D.
    Rezvani, K.
    Fang, S.
    Monteiro, M. J.
    Li, S.
    Li, X-J.
    Wang, H.
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2011, 31 (05) : 737 - 747
  • [2] The contribution of glial cells to Huntington's disease pathogenesis
    Wilton, Daniel K.
    Stevens, Beth
    NEUROBIOLOGY OF DISEASE, 2020, 143
  • [3] Recent advances on the pathogenesis of Huntington's disease
    Petersén, Å
    Mani, K
    Brundin, P
    EXPERIMENTAL NEUROLOGY, 1999, 157 (01) : 1 - 18
  • [4] Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies
    Tong, Huichun
    Yang, Tianqi
    Xu, Shuying
    Li, Xinhui
    Liu, Li
    Zhou, Gongke
    Yang, Sitong
    Yin, Shurui
    Li, Xiao-Jiang
    Li, Shihua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [5] Modeling Huntington's disease in cells, flies, and mice
    Sipione, S
    Cattaneo, E
    MOLECULAR NEUROBIOLOGY, 2001, 23 (01) : 21 - 51
  • [6] Modeling Huntington's disease in cells, flies, and mice
    Sipione S.
    Cattaneo E.
    Molecular Neurobiology, 2001, 23 (1) : 21 - 51
  • [7] Huntington Disease Pathogenesis and Treatment
    Dayalu, Praveen
    Albin, Roger L.
    NEUROLOGIC CLINICS, 2015, 33 (01) : 101 - +
  • [8] Are there multiple pathways in the pathogenesis of Huntington's disease?
    Aronin, N
    Kim, M
    Laforet, G
    DiFiglia, M
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 995 - 1003
  • [9] Microglial Activation in the Pathogenesis of Huntington's Disease
    Yang, Hui-Ming
    Yang, Su
    Huang, Shan-Shan
    Tang, Bei-Sha
    Guo, Ji-Feng
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [10] Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington's disease
    Saha, Sudeepto
    Dey, Manami Jayati
    Promon, Salman Khan
    Araf, Yusha
    REGENERATIVE THERAPY, 2022, 21 : 406 - 412